{"SPADE_UN_15466": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15466", "Peptide Name": "SFTI-1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "CTKSIPPICFPDGR", "Sequence Length": 14, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q4GWU5"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)", "Hemolytic Activity": "Human red blood cells:no hemolytic activity(as show in Fig.4)", "Cytotoxicity": "HUVEC:IC50>100 μM", "Binding Target": "pigment epithelium-derived factor; somatostatin", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C67H108N18O19S2", "Mass": 1533.81, "PI": 8.06, "Net Charge": 1, "Hydrophobicity": -0.13, "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy", "Pubmed ID": "27734947", "Reference": "Sci Rep. 2016 Oct 11;635019.", "Author": "Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=27734947"}], "Frequent Amino Acids": "PCI", "Absent Amino Acids": "AEHLMNOQUVWY", "Basic Residues": 2, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 6, "Positive Residues": 2, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17333", "Similarity": 1.0, "Sequence": "GRCTKSIPPICFPD"}, {"SPADE_ID": "SPADE_UN_17334", "Similarity": 1.0, "Sequence": "GRCTKSIPPICFPD"}, {"SPADE_ID": "SPADE_UN_17335", "Similarity": 1.0, "Sequence": "GACTKSIPPICFPD"}]}}}